It’s All in the (Pharmaceutical Drug) Name

by Justine Landis on 9/9/15 12:30 PM

Have you ever wondered how new drugs get their complicated names? Who gets to make these decisions and do they purposely test our ability to phonetically pronounce these terms? While it may seem like the pharmaceutical drug makers...

Orphan drug development: a market worth adopting

by Mary Calvagna on 11/7/12 9:00 AM

Have you heard the term orphan disease before? Despite the name, it does not mean diseases that preferentially affect orphans. An orphan disease is a condition that affects fewer than 200,000 people nationwide. Some orphan...